All posts by admin

Anaphylaxis – management

Management of anaphylaxis involves treating the acute emergency, in the community first (see adrenaline autoinjectors), then in hospital, and then arranging appropriate follow up.  See also anaphylaxis definition.

Hospital

APLS guidelines (updated 2021) on management of acute anaphylaxis from the United Kingdom Resuscitation Council.

No distinction between anaphylactic and anaphylactoid reactions – confusing and may lead to inadequate treatment. Patients taking beta blockers may have a more severe reaction and respond less well to adrenaline.

Adrenaline is the only evidence based treatment specified in the guidelines.  It is therefore the treatment of choice.  You could argue that anaphylaxis is the one condition in which the ABC approach is not appropriate – as soon as anaphylaxis is suspected, you should give intramuscular adrenaline, and then proceed to airway, breathing etc.

Adrenaline is underused. 34% of cases of anaphylaxis in Patel’s metanalysis did not receive adrenaline (my calculation from table III); 10% needed more than 1 dose [Patel JACI 2021]. In scenario based studies, adrenaline is often not given.

Adrenaline by the intramuscular route is safe. If in doubt, just give it! Dose is 0.15mg for under 6yrs, 0.3mg for 6-12yrs, 0.5mg for over 12.  This is slightly different from the adrenaline autoinjector dose the child may have been prescribed for home use.

Repeat within five minutes if there is no improvement or if the patient’s condition deteriorates – not based on any evidence!

New guideline does not mention steroids or antihistamines at all! But does include IV bolus with second dose IM adrenaline after 5 minutes. 

Posture emphasised in new guidance – Lie down with legs raised, or allow sitting up in semi-recumbent position if that helps breathing. Beware sitting up, standing and walking even if feeling better – reported trigger for cardiac arrest – so caution when transferring.

Consider doing tryptase level if unclear trigger or if doubt whether it is anaphylaxis or panic attack, at earliest opportunity then repeated at 1-2 hours, and ideally again at later date to check baseline (raised would suggest mastocytosis).

Refractory Anaphylaxis

After that, if still not improving, there is a new Refractory anaphylaxis guideline. 

  • Get expert help.  Intravenous adrenaline should only be given by experienced practitioner.
  • Further IV bolus [regardless of resp/circulatory signs]. Repeat IM adrenaline ever 5 minutes while setting up low dose IV adrenaline infusion:
    • 1 mg (1 mL of 1 mg/mL [1:1000]) adrenaline in
      100 mL of 0.9% sodium chloride, ie 1:100 000.
    • Beware BP cuffs and piggy back lines that will interfere and potentially cause extravasation. 
    • Start at 0.5-1ml/kg/hr and titrate.
    • Use ECG monitoring. 
  • Use nebulised adrenaline for stridor, neb salbutamol etc for wheeze or bronchospasm. 
  • After that, intubation, inhalational anaesthetics (good for bronchospasm), repeat fluid boluses, additional inotropes…

Discharge

Before, advice was observe for 6-12 hours, or admit if child. Now this has been risk stratified, with 6-12 hour rule applying for most cases. Exceptions are:

  • 2hr discharge if a) good response (5-10 minutes), to b) single dose adrenaline, c) given within 30 mins PLUS complete resolution PLUS already trained and with 2 unused AAIs PLUS adequate supervision
  • At least 12 hours after resolution if any of:
    • severe, needed more than 2 doses adrenaline
    • severe asthma, or had severe respiratory compromise
    • possibility of ongoing absorption eg slow release medication
    • late at night or potential to not respond to any deterioration
    • areas where emergency care difficult
  • or in context of supervised challenge

No reliable way to predict biphasic reaction so this should be discussed and decision made by senior clinician.

Follow up

See NICE guideline CG134.

Basic principles are to not discharge too soon, in case of a biphasic attack, but just as importantly, to consider prevention of further episodes (which involves making a diagnosis), and giving the patient and their family the appropriate information and skills to deal with an unexpected further allergic reaction.

Liverpool study (adults and children, I presume) found IM adrenaline given in 91.7% of cases, recommended observation period (6–12 h) achieved in 91.7% of patients. Long-term management not great – adrenaline auto-injector prescriptions provided to 50% of patients, “structured patient education” documented in 17.9% of cases, and allergy clinic referrals in 42.9%.

Who needs an Adrenaline auto-injector?

EAACI position paper suggests:

  • Absolute indications:
    • Previous cardiovascular or respiratory reaction to a food, insect sting or latex.
    • Exercise induced anaphylaxis.
    • Idiopathic anaphylaxis.
    • Child with food allergy and co-existent persistent asthma.
  • Relative indications:
    • Any reaction to small amounts of a food (e.g. airborne food allergen or contact only via skin).
    • History of only a previous mild reaction to peanut or a tree nut.
    • Remoteness of home from medical facilities.
    • Food allergic reaction in a teenager.

Prescribing a pen is only part of the overall management: nothing worse than prescribing a pen and not properly discussing avoidance, or having a pen that does not get used when it should be, because it’s left at home or because no-one remembers how to use it or they are too scared to use it.

Referral to an allergist is highlighted.  According to a Mayo Clinic study, 35% of those referred by emergency department (ED) had an alteration in the diagnosis or suspected trigger after allergy/immunology follow up.  Either anaphylaxis was ruled out; or an unknown trigger was successfully identified; or the suspected trigger was ruled out.  Allergists are also good at identifying new triggers, different from the one suspected (JACI In Practice 2014)

How well is anaphylaxis managed by emergency departments?

In 1 study from Arkansas, n=187 patients (all under 19), food (44%) and stings (22%) were the main triggers, whereas 29% had no identifiable allergen. Only 47% (n = 87) received adrenaline in the ED and only 31% of those via the preferred IM route (the rest were treated subcutaneously). 61% received autoinjectors at discharge. Only 45% received an allergy referral. [Ped Emergency Care 2016] Similar results from Birmingham, Alabama in 2010.

Most cases of anaphylaxis are coded as “allergic reaction” rather than anaphylaxis, which suggests hospital statistics are likely to represent only a minority of the cases coming to hospital. In the study above, before the 2006 NIAID anaphylaxis guidelines, only 20% of cases were accurately coded.

Anaphylaxis

See also:

Anaphylaxis is usually defined as an acute systemic allergic reaction with compromise airways, breathing and/or circulation.  Systemic here means that the reaction is not limited to just one body system (skin, GI, respiratory etc) but spreads to others.  It is usually – but not exclusively – mediated by IgE-antibodies.

There are however 5 different international definitions – not all include systemic, and of course not all systemic are anaphylaxis (for example skin and gut, 2 systems, not usually called anaphylaxis – except 2016 NIAD/FAAD definition in US, which specifies “persistent gut symptoms”).  Respiratory involvement alone sometimes not called anaphylaxis by experts, even when treated as such! 3 definitions use “life threatening” but that is somewhat subjective and poses the danger of delaying appropriate management until the reaction is already advanced. 

Use of the word “anaphylactic” is discouraged in the Resus council guideline, unless talking about anaphylactic shock, as it is misused to describe patients at risk of anaphylaxis (they may describe themselves as such), whereas this is actually anyone with a type 1 allergy.  

Anaphylactoid reactions are immediate systemic reactions that mimic anaphylaxis but for which an IgE-mediated immune mechanism can not be established – most people don’t bother trying to make a distinction now.

Resuscitation Council definition (2021):

  • Sudden onset, rapid progression
  • Airway/breathing/circulation problems (not specified)
  • “Life threatening” includes:
    • hoarse voice, stridor
    • wheeze, work of breathing, cyanosis, fatigue
    • Signs of shock (presumably pale, clammy), low BP, confusion, reduced consciousness
    • (not tongue swelling or persistent cough)

EAACI task force anaphylaxis criteria (2007, from Sampson): any one of –

  • acute onset (up to several hours) skin/mucosa reaction (eg generalized hives, pruritus or flushing, swollen lips/tongue/uvula) plus respiratory or cardiovascular compromise eg dyspnoea, bronchospasm, stridor, hypoxia, hypotension, collapse
  • acute onset after exposure to likely allergen of at least 2 of: skin/mucosa changes, resp, cardio compromise, persistent GI (eg crampy abdo pain, vomiting)
  • hypotension after exposure to known allergen for that individual

Note that this definition talks about “compromise”, and the examples given are mostly signs that only a medical professional could identify!  This doesn’t help patients/parents.  It also allows for anaphylaxis with just skin and persistent GI symptoms (where likely allergen exposure).

anaphylaxis grading sampson peds 2003
Anaphylaxis grading Sampson 2003

In Sampson’s original 2003 criteria, he grades anaphylaxis into 5 types. 1 and 2 would not be considered anaphylaxis these days at all!

WAO 2020 revised definition, based on input from 15 different allergy societies – “highly likely when any 1 of -“

  • acute onset skin/mucosa plus one of airway/breathing compromise, circulation, severe GI, or
  • acute hypotension, laryngeal involvement, bronchospasm [specifically] after likely exposure, even without skin symptoms.

BSACI’s allergy plan includes as severe symptoms hoarseness, dysphagia but also:

  • persistent cough,
  • noisy breathing
  • tongue swelling
  • persistent dizziness, pale/floppy, suddenly sleepy

AAP also has cough, hoarse, PLUS severe vomiting and diarrhoea, “many hives”(!), agitation.

On logistic regression, confusion and incontinence were strongly associated with hypotension and hypoxia. Dizziness, vomiting, abdominal pain, dyspnea and chest/throat tightness had weaker, albeit significant, associations. Pre-existing lung disease was associated with an increased risk of hypoxia. [Journal of Allergy and Clinical Immunology Volume 114, 2004, 371-376]

In a survey of kids with anaphylaxis, the mean latent period was 15.4 (SD27.5) minutes, ie 95% will react within 90 minutes of exposure. The type of allergy does not predict the latency well; however, age is inversely related, with younger children having more gradual onset. GI and cardiovascular symptoms tended to come later than skin/respiratory. 60% of anaphylactic reactions occurred in the home, and 10% happened in health care environments. Males predominate, particularly with regards exercise induced and insect venom anaphylaxis [PEDIATRICS Vol. 101 No. 4 April 1998].

Biphasic anaphylaxis

About 20% to 30% of food-induced anaphylactic events have a biphasic or recurrent response, although only half of those severe. 90% of recurrent reactions within 12 hours. Delay in giving adrenaline increases risk of recurrence! Some anaphylactic reactions are persistent, going on for hours.

Recognition

Recognition of anaphylaxis can be poor by non-experts. It is sometimes assumed that anaphylaxis must be life threatening, and that it must be progressive to the point of shock/collapse. Well recognised that anaphylaxis can resolve without treatment in some cases. Some have called for anaphylaxis grading, such as Sampson’s, but this then undermines the basic distinction.

Equally, people will sometimes diagnosis anaphylaxis on the basis of severe facial swelling, or widespread rash, neither of which are criteria.

Part of the problem of course is that what parents report is not the medical terminology included under the definitions. Infants and toddlers are a particular problem, since they cannot describe what they feel, and hypotension/syncope are extremely late signs. In US study, 48% of caregivers recognized 1 or more less obvious symptoms of anaphylaxis only in retrospect [but that includes skin/tongue/GI symptoms: looking at table II, 15% recognised sudden behaviour change in retrospect, 11% cough/wheeze, 6% wobbly/lethargy, difficult to rouse – can’t add up though]– that lack of recognition may affect management by medical team.

US 2024 study (Handorf) proposes modified NIAID/FAAN criteria – swollen tongue/uvula/pharynx becomes respiratory, not mucocutaneous; adds cough, drooling, hoarse cry/voice to respiratory too; specifies gagging, spitting up, diarrhoea, back arching as GI; pallor, mottling, obtunded/lethargy, altered mental state as CVS. By these criteria, 52% of all ED visits in children under 5 then became “anaphylaxis” (includes those given that diagnosis by attendings plus some ambiguous cases determined by clinicians to be anaphylaxis). Attendings diagnosed anaphylaxis in 68% of cases, but falls to 59% in infants. Original NIAD/FAAN criteria have 85% sensitivity, but falls to 77% infants. Modified criteria 100% sensitive for infants; 96-98% of older children. Compared with NIAD/FAAN, modified criteria picked up 43% more CVS signs, and 32% respiratory. Only 5% increase in GI. No hypotension/syncope in infants/toddlers, as expected.

Epidemiology

UK hospital admissions for food anaphylaxis have increased by 6.6% each year between 1998 and 2018 for under 15s (about 3x increase over whole period). For other ages much lower increase. Possibly due to 4hr waiting time rules for emergency departments? Or NICE recommendation on observation after suspected anaphylaxis? Case fatality rate has gradually fallen over time. At least 46% of all deaths triggered by peanuts or tree nuts. Cow’s milk responsible for 26% of deaths in school aged children (and rising), which shows how serious it can be when you don’t grow out of it in infancy. About a quarter trigger unknown (no comment – presumably no details in coding, rather than actually unknown), peanut and tree nuts together about a third. AAI prescriptions over the same period have increased by 336%.

Commentary by authors talks about effects on family of food allergy diagnosis but then goes straight into reasons for overdiagnosis, either through self reporting, commercial pressures, even campaigning by allergy charities. They say it is a “familiar pattern” with sharp increases in softer indicators of allergy, but no increase in markers of severe disease, and that this is the case in other countries such as the US and Australia. They conclude that we live in an era of increasing concern and awareness, but not a food allergy epidemic.

Whether the data are reliable, is a whole other question. Anaphylaxis is not well recognized, treated or documented, and only cases that were admitted were included, so these cases are probably just a fraction of what is actually coming to emergency departments. That doesn’t matter so much if that fraction stays the same and you’re only interested in trends. But even the interpretation of their own data seems curiously sceptical – if it is true that allergy is no more common than it was at any time in the last 30 years, are we saying families in the past just didn’t bother bringing their children to hospital when they had anaphylaxis? Or just more likely to admit (as NICE guidance from 2011 encourages observation for at least 6 hours, although the authors themselves say this probably only produced a minor increase in cases)?

Falling rates in peanut/nut, better awareness esp industry? Whereas milk awareness low? Although milk allergy common in young children, 5% of deaths in adults still due to milk (and prob harder to spot than nuts in food).

Higher rates of food anaphylaxis admissions in boys before puberty (male-to-female ratio 1.6:1), but reverses from age 15 years onwards. Highest rates of admission and death in teenagers, but in this study this risk continues through into mid adulthood, so supports the idea that it’s not specifically “teenage behaviour” that increases risk, rather biological vulnerability. In children under 5, deaths rare even though highest rate of admission.

[Conrado, BMJ 2021]

Risk Factors

Fatal anaphylaxis rate is about 1 in ¼ million. Risk of hospital admission with anaphylaxis 1 in 10 000. More likely to die on way to hospital appointment!? Doesn’t mean we avoid driving. Important to see that there can be an “acceptable risk” of living with food allergy.

Although there are a range of associations, most of these are very weak, which makes them unhelpful, or even misleading.

There is also a difference between sensitivity and severity. Some children during food challenges may only start reacting after a relatively high threshold dose – but their reactions tend to be worse, not unexpectedly.

Exercise is an important factor esp in teenagers, can even (rarely) be the sole identifiable trigger! See Exercise-Induced Anaphylaxis.

Statistically, females have worse reactions. In mice, the difference appears to be due to effect of oestradiol on increased tissue expression of eNOS (one of the NO synthases).

Medication – eg beta blockers, NSAIDS may increase risk.

Sleep deprivation reduced threshold in UK TRACE peanut study!

Most food anaphylaxis related to nuts (including peanut) and milk, but this is partly just how frequent these allergies are and how frequently the foods are encountered.

Deaths

Mostly in children over 5, despite the fact that food allergies are more common under 5 and usually lessen with time. Families often assume risk is higher in young children, which is incorrect. Nearly all are in children with asthma. Of the 8 deaths between 1990 and 2000, 4 were due to milk, 2 peanut, 1 egg and 1 mixed (but see below for bigger study). Both the peanut deaths were in children over 13yrs. Children are over 250x more likely to die in road traffic accident, although this is hardly a fair comparison.

Mortality and morbidity higher where adrenaline not used – so education (patient, family and health care) important, specifically recognition and management, giving out allergy care plans.[https://doi.org/10.1016/j.anai.2017.06.004]

Fatal Anaphylaxis Registry – set up in 1994 by Dr Richard Pumphrey based at Manchester University NHS Foundation Trust. This is now evolving into a European wide anaphylaxis registry.

In 80% of fatal anaphylaxis cases [mixed causes], adrenaline not given before arrest, which suggests delayed administration could be a factor. Same study shows that adrenaline does not prevent death even when given before arrest.

Most cases were in people with no previous history of anaphylaxis [but how many nut+asthma, where higher risk recognised?]

Survival better if adrenaline given within 30 mins [1992 Sampson article NEJM].

1 death at 6 hours, despite repeated adrenaline. 1 death after intentional consumption, despite immediate epipen administration.

So avoidance and asthma management are arguably more important than providing adrenaline autoinjectors! [Pumphrey]

Differential

If test unexpectedly negative, wait and repeat test (anergy if recent reaction well known in drug allergy, less clear if relevant to food allergy).

Test with raw food rather than commercial product, in case relevant protein under-represented.

Where no cause identified consider:

Differential includes mast cell disorders, asthma, panic attacks, conversion disorder, globus hystericus, vocal cord dysfunction, scombroid poisoning, vasoactive amine intolerance, carcinoid syndrome and phaeochromocytoma. 

Haemophagocytic syndromes

A group of disorders, including haemophagocytic lymphohistiocytosis, Macrophage activation syndrome, and PIMS-TS. Suspect when these unexplained or unusually severe, particularly in combination:

Anti-emetics

Oral Ondansetron use for gastroenteritis has become v popular in many emergency departments.  In 1 study of 18 EDs, where it was a standard in nearly half all cases, there was no overall improvement in rates of either intravenous rehydration (remained around 18%) or hospital admission. There was a small decrease in re-attendance rates.

There was also a wide variation between institutions: perhaps the problem is not using Ondansetron it correctly eg not giving it soon enough, or rushing into IV fluids before allowing the drug time to work

Same group looked at Ondansetron in diabetic children with vomiting, again, usage increased from 0 to 67%. Admission rates dropped from 62% to 49% between these eras, as did use of IV fluids, but Ondansetron had no independent benefit.

From Archimedes Blog.  (Freedman S et al. JAMA Pediatr 2014;168:321–29, see also Editorial)( (Leung J et al. J Pediatr 2014. doi.org/10.1016/j.jpeds.2014.10.020). )

Tremor

Essential tremor develops insidiously and progresses slowly.  May start in a single limb, but it becomes bilateral over time.  Flexion-extension movement of the wrist, frequency of 4 to 12 Hz. May involve head (yes-yes or no-no). Worsens with stress, fatigue, and may increase with some voluntary activities eg holding a fork or cup. Rest, beta blockers, and alcohol help.  Often a family history.

Compare Cerebellar tremor – low-frequency (less than 5 Hz), intention tremor.  May include postural element (ie at rest).  Other signs include abnormalities of gait and speech, nystagmus, dysdiadochonesis (inability to perform rapid repeated hand movements).  Titubation is the word given to rhythmic movements of head/neck seen in cerebellar disease.

So ask patient to extend arms.  Do Finger-to-nose, finger-to-finger, and heel-to-shin testing (Cerebellar).  Observe drinking from glass, writing name, drawing spiral (or draw within lines of pre-printed spiral).  Check for tone (rigidity), esp when busy using other limb, eg draw a circle in the air) – basal ganglia, eg Parkinsons. Check gait (shuffling?  Ataxic?), eye movements.

Look for signs of space occupying lesion, thyroid or liver disease.  Any chance of intermittent hypoglycaemia?  Panic disorder?  Withdrawal?

Domperidone

Children with congenital heart disease – Consider stopping domperidone therapy or discuss with parents/carers and ensure that cardiac monitoring is regularly performed. Consider offering an alternative treatment where appropriate.

Other children with established reflux or nausea and vomiting – Take no immediate action in patients already established on domperidone.   Consider reducing the dose (where appropriate) to 250microgram/kg three times a day at the next convenient review. Consider routine cardiac monitoring where there are concerns (e.g. cardiovascular instability,
concomitant CYP3A4 inhibitors prescribed).

In new patients, always give a proper trial of feed thickeners before considering pharmacological intervention – at least two weeks. In more serious cases, and after the introduction of thickeners then consider the benefits and risks of medical anti-reflux/anti-acid secretion treatment.

If domperidone is to be used, give an initial maximum of
250micrograms/kg three times a day. Where reflux or nausea is refractory to
this then give increased doses to a maximum of 400micrograms/kg (max
20mg) three times a day and recommend regular cardiac monitoring.

Patient Information Leaflet entitled “Domperidone for gastrooesophageal
reflux” available from www.medicinesforchildren.org.uk

SUDI – Risks

Long list of known risk factors, even though mechanism not clearly understood!

Age is probably the main risk factor – mostly 5-10 weeks of age. Very few in later infancy (although sudden death is described in all ages cf SUDEP).

From Scottish study –

So preterm, low birth weight boys with socially deprived unmarried mothers who smoke are at highest risk. But many of these factors compound and confound – 78% have at least 2 risk factors, only 0.8% have no risk factors. If you exclude “non-modifiable risk factors” (social deprivation, etc), only 5.3% have no risk factors.

Prone sleeping is no longer a major factor since it has been discouraged for years. Might be protective for preterms, where found to promote cortical arousal (CA) responses (protective in term infants). Horne 2013

36% of excess infant mortality in US South due to SUDI (90% of excess mortality in Kentucky!  59% due to non-hispanic black population).

Main risk factor now is co-sleeping, esp on sofa, although this is commonly associated with alcohol/drug use. Blair & Sidebotham BMJ 2009

Note used mattress is risk factor in Scotland – never replicated elsewhere.

Dummies are protective, even though they fall out – part of some national safe sleep recommendations but not in UK (perhaps because mechanism unclear?).

Parental mental health associated – if both have a mental health disorder, OR for SIDS =6, more if substance abuse disorder – but smoking/social deprivation explains 50% of this risk.

4% of unselected cases had long QT mutations [NZ] – increased to 16% when cases guided by cardiac genetics.  But poor uptake of screening!

A previous maltreatment report emerged as a significant predictor of SIDS and other SUID. After adjusting for baseline risk factors, the rate of SIDS was more than 3 times as great among infants reported for possible maltreatment (hazard ratio: 3.22; 95% CI: 2.66, 3.89).  [US, PMID 24139442]

SUDI – prevention

NICE CG194 [postnatal care] covers.

Smoking cessation advice.

Discuss with parents safer practices for bed sharing:

  • making sure the baby sleeps on a firm, flat mattress, lying face up (rather than face down or on their side)
  • not sleeping on a sofa or chair with the baby
  • not having pillows or duvets [bumpers etc] near the baby

“Strongly advise” parents not to share a bed with their baby if:

  • baby was low birth weight, 
  • or if either parent:
    • has had 2 or more units of alcohol [not zero tolerance! Interesting…]
    • smokes
    • has taken medicine that causes drowsiness
    • has used recreational drugs.

And that’s it!!!

Note that the word “risk” is not used, just association!  Boys as being at higher risk not mentioned!

PreBotzinger complex (preBotC) is a multi-functional neuronal network that is critically involved in the response to hypoxic and hypercapnic challenges.

Note increased brain oxygen requirement during “active sleep” cf quiet sleep.  Only apparent between 2 weeks and 5 months.  [Horne 2014].

Dutch recommendations include: (a) pre-term neonates born after 32 weeks should be placed in a supine position; (b) twins should not sleep in the same bed (‘co-bedding’); (c) use of a pacifier is recommended once breastfeeding is well underway; and (d) use of stabilization pillows is not recommended [PMID 23425715]

Psychosocial interventions

Flashpoints are transition eg from nursery to primary, to secondary, to adult services.

At diagnosis, constantly try to normalise.

Other triggers are new or difficult situations: staff changes esp specialist nurses. Effect on parent’s work, parent’s role in family, child’s fears.

Past experience of medical condition, procedure, hospital/doctors will colour.

Parenting in chronic illness – limit setting vs laxity (love!) in face of illness.

Behaviour as communication of fear, displeasure!

Signs and symptoms – changes in appearance, mood, behaviour, thoughts.

Support at diagnosis: names, phone numbers! Normalise experience and feelings. Signpost peer support, online or other. Written. Practical eg financial, family routines. Joint working for consistent info. Deciding what chats are appropriate with child present. Reiteration.

“Other people in your situation have tried x, y and z. Do any of those sound good?”

Pre-5: encourage play and exploration, avoid interfering with parental proximity.

5-7 May develop magical thinking (I think, and it comes true). Guilt, punishment, contagion? Accept what other children say as true! Imitate parental behaviour. Death as reversible.

Drawing! Check understanding of bodily functions.

Sue Robinson, hospital passport (Janie donnan). For primary school age, app for teens to follow.

Concrete reminder of achievements and rewards.

Alphabet. Backwards!

Hand on tummy, feel rise and fall.

Guidance for parents!

Sucrose. Video for juniors, showing expected techniques.

Functional analysis (ABC) – immediate antecedent (context as much as events), consequences (esp people’s actions, any difference in attention (anything given or taken away)?  What would usually happen otherwise?) use diary again. Bedside table! 5-7 days max, can be repeated. Review within 2 weeks.

Pacing – beware boom/bust cycles. Rest before exhausted but maintains daily activity.

Activity record: enjoyment vs pain impact.

Smart goal. Low hanging fruit first! Goal diary – did you achieve it? Rate pain. How did you feel?

If/then plan – beware abandoning at first set back. If you can’t get to school one day, then what will you do? Phone to update? Try harder next day?

How confident? What benefits, what difficulties?

Visualisation – can child describe a scene easily? Else unlikely to work.  Personally relevant dream place. Safe and happy. Real or imagined. Describe it in as much detail as you can – all senses. As long as possible; but 5 mins is plenty.

Record positive achievements.

Positivity – but listen empathetically.

Negative beliefs.

 

[NES study day – Liz Hunter, Ashley Sikoura]

Febrile Convulsions

Typical febrile convulsions are:

  • age 6 months to 6 years
  • Normal neurodevelopment
  • generalized, tonic-clonic

Most important differential is CNS infection eg encephalitis, meningitis.  These tend to present with posturing, impaired conscious level, or focal seizures. 15% of patients presenting with status epilepticus with fever have meningitis (observational study) – although low rate of LP so underestimate? I suspect there would have been other features to suggest meningitis beforehand.  Stiff neck? Fear of doing LP due to RICP from fit and/or meningitis, so do CT first if in ICU or abnormal neurology else as soon as no contraindication. If in doubt, treat empirically for meningitis (+/- herpes encephalitis, although risk unknown) with antibiotics and steroids. [Chin RFM, Arch Dis Child 2005;90:66-9.(Ed by Kneen)]

About 30-35% of febrile convulsions in the absence of CNS infection however have one or more complex features:

  • focal onset,
  • duration >10 minutes,
  • or multiple seizures during the illness episode

Febrile status epilepticus, a subgroup of complex febrile convulsions with seizures lasting more than 30 minutes, occur in about 5% of cases.  [BMJ 2015; 351 doi: http://dx.doi.org/10.1136/bmj.h4240 ]

Recurrence

One third of children with febrile convulsions will experience further seizures; age is the single, strongest, and most consistent risk factor. Most recurrences will occur during the first year and over 90% recur within two years (so unlikely to happen later). Other risk factors for recurrence are –

  • family history of febrile convulsions (but not epilepsy) in a first degree relative,
  • children whose initial seizure occurred with a relatively low fever,
  • multiple initial seizures occurring during the same febrile episode.

Surprisingly, status in an otherwise normal child does not appear to significantly increase the risk for further febrile seizures or the development of epilepsy.

Information for Families

From European Journal of Pediatrics 2021: